Search
Neurotech founder Adrian Trevisan (left) with chief executive Wolfgang Storf.

Neurotech raises $4m for medical device

Medical technology company Neurotech International has tapped investors for $4 million to fund further development of its Mente Autism device.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 28/02/20

1 year TSR5 year TSR
630thAltech Chemicals-44%-2%
752ndOakajee Corporation-62%-3%
798thNeurotech International-73%
799thProtean Energy-73%-51%
671 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

25/02/19
$0 Issued
25/02/19
$0 Issued
25/02/19
$0 Issued
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

161st↑Neurotech International$246k
188th↑Altech Chemicals$0
189th↑HearMeOut$0
191st-Oakajee Corporation$0
192nd↑Protean Energy$0
198 listed industrial companies ranked by revenue.
Powered by Morningstar ®